Kristin C Peck has sold ZTS and made no open-market buys since Nov 2016

Kristin C. Peck is the Chief Executive Officer of Zoetis Inc. (NYSE: ZTS), the world’s leading animal health company and a Fortune 500 organization, and she also serves on the company’s Board of Directors.( She became CEO in 2020 after holding senior roles including Executive Vice President and Group President for U.S. Operations, Business Development and Strategy, where she helped lead Zoetis through its 2013 initial public offering and oversaw businesses such as Global Manufacturing and Supply, Global Poultry, Global Diagnostics, Corporate Development, and New Product Marketing and Global Market Research.( Under her leadership, Zoetis has delivered strong financial growth and industry‑leading operating margins, launching numerous blockbuster products and building a robust innovation pipeline.(

Before joining Zoetis, Peck served as Executive Vice President, Worldwide Business Development and Innovation at Pfizer Inc., sitting on Pfizer’s Executive Leadership Team and working earlier in her career in consulting at The Boston Consulting Group and in private equity and real estate finance at The Prudential Realty Group, The O’Connor Group, and J.P. Morgan.( Beyond Zoetis, she serves on the boards of BlackRock, Mayo Clinic, Columbia Business School, Catalyst, and is a member of the Business Roundtable, among other governance roles, reflecting her broader influence in corporate leadership and healthcare.( Peck holds a bachelor’s degree from Georgetown University and a Master of Business Administration from Columbia Business School, where she remains engaged through advisory and board service.(

Written by Perplexity from public sources.